10.5061/DRYAD.D5279D1
Peng, Panxin
Peking University
Lai, Shicong
Ding, Zhenshan
He, Yuhui
Peking University
Zhou, Lihua
Peking University
Wang, Xuming
Zhang, Guan
Peking University
Data from: One-shot dilation versus serial dilation technique for access
in percutaneous nephrolithotomy: a systematic review and meta-analysis
Dryad
dataset
2019
tract dilation
percutaneous nephrolithotomy
one-shot dilation
serial dilation
2019-03-08T16:14:32Z
2019-03-08T16:14:32Z
en
https://doi.org/10.1136/bmjopen-2018-025871
34602 bytes
1
CC0 1.0 Universal (CC0 1.0) Public Domain Dedication
Objective: The purpose of this study was to systematically review the
outcomes of the use of one-shot dilation (OSD) and serial tract dilation
for percutaneous nephrolithotomy (PCNL). Methods: A systematic review and
meta-analysis was conducted. The randomized controlled trials (RCTs)
included in the study were identified from EMBASE, MEDLINE, and the
Cochrane Central Register of Controlled Trials. The last search was
performed on April 30, 2018. Summary effects were calculated as risk
ratios (RRs) with 95% confidence intervals (CIs) or mean differences (MDs)
with 95% CIs. The endpoints included access time, fluoroscopy time,
successful dilation rate, stone-free rate, postoperative decrease in
hemoglobin levels, transfusion rate, complication rate, and length of
postoperative hospital stay. Results: A total of 7 RCTs were included in
the study, with clinical data reported for 697 patients. The overall
access time was approximately 110 seconds shorter in the OSD group than in
the serial dilation group (MD, -110.14; 95% CI, -161.99 to -58.30;
P<0.0001). The fluoroscopy time was shorter with OSD in all RCTs.
In addition, the decrease in postoperative hemoglobin levels was
approximately 0.23 g/dl less in patients in the OSD group than in those in
the serial dilation group (MD, -0.23; 95% CI, -0.39 to -0.07; P=0.004). No
relationship was found between the successful dilation rate, stone-free
rate, transfusion rate, or complication rate and the method of tract
dilation. Conclusion: OSD is a safe and efficacious tract dilation
technique that can reduce the access time, fluoroscopy time, and
postoperative decrease in hemoglobin level. No difference was found in the
successful dilation rate, stone-free rate, transfusion rate, or rate of
complications between the OSD and serial dilation groups. The difference
in the length of postoperative hospital stay was uncertain. OSD may be a
better method of tract creation for PCNL.
DataSharing_DryadData from: One-shot dilation versus serial dilation
technique for access in percutaneous nephrolithotomy: a systematic review
and meta-analysis .